Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer.
Cancers (Basel). 2021 Jun 11;13(12):2922. doi: 10.3390/cancers13122922.
Cancers (Basel). 2021.
PMID: 34208071
Free PMC article.
Review.